US Infectious Disease Trends: Measles Back, Flu Climbing the Ranks

Coloured electron micrograph of a single measles virus particle
A measles virus particle, colourised transmission electron micrograph. Photo: NIAID via Wikimedia Commons, public domain.
RisingUpdated 4 October 2026

Trend summary

  • Measles, declared eliminated in the US in 2000, is spreading again. As of 1 October 2026 the CDC had confirmed 3,887 cases this year, against 2,289 in all of 2025.
  • Cases have been reported in 47 states and DC, 95% of them linked to outbreaks; two deaths have been reported so far in 2026.
  • The 2025–26 flu season caused an estimated 32 million illnesses, 380,000 hospitalisations and 24,000 deaths, with 166 child deaths.
  • Influenza and pneumonia rose from the 11th to the 8th leading cause of death in 2025 provisional data.
3,887measles cases, 2026 to 1 Oct
2,289measles cases, all of 2025
24,000estimated flu deaths, 2025–26 season
166child flu deaths, 2025–26

What the numbers show

The CDC measles page lists 3,887 confirmed cases as of 1 October 2026, 42 new outbreaks this year and 3,700 outbreak-associated cases. The agency notes that 2025–2026 counts are preliminary.

For flu, CDC FluView rated the 2025–26 season moderate overall but of high severity in children, with influenza A(H3N2) dominant. About 85% of the children who died and whose status was known had not been fully vaccinated. NCHS provisional mortality data show influenza and pneumonia deaths at 56,511 in 2025, up from 48,139 the year before (NCHS).

What is driving it

Measles needs about 95% vaccination coverage to stop spreading, and pockets of low uptake let imported cases ignite local outbreaks. Flu severity varies with the dominant strain and how well that year’s vaccine matches it. Both are tracked weekly, so this page moves faster than most others in this section.

Policy and budget changes

The main government measures and money figures behind this risk, newest first. Each item links to the official text we checked; where only a news report was available, the source says so.

Main policy changes

  • 3 August 2023 RSV antibody recommended for infants. The CDC’s Advisory Committee on Immunization Practices recommended nirsevimab, a long-acting antibody, for all infants under 8 months born during or entering their first RSV season, and for some higher-risk children aged 8–19 months. (CDC, MMWR)
  • 21 June 2023 First RSV vaccines recommended for adults 60 and over. ACIP voted that adults aged 60 and over may receive a single dose of an RSV vaccine, based on shared clinical decision-making with their doctor. CDC published the recommendation in July 2023. (CDC, MMWR)
  • 11 May 2023 COVID-19 public health emergency ends. The federal COVID-19 Public Health Emergency expired at the end of 11 May 2023. Vaccines stayed available at no cost under CDC agreements, but HHS lost the power to require laboratories to report COVID-19 test results, and hospital reporting moved from daily to weekly. (US Department of Health and Human Services)
  • 19 January 2017 CDC updates federal quarantine regulations. The CDC published a final rule, effective 21 February 2017, updating federal quarantine and isolation regulations. It adds due-process protections such as medical review, and requires airlines on commercial passenger flights to report deaths and illnesses to the CDC. (Federal Register (CDC final rule))

Budget and costs

  • 8 August 2024 Childhood vaccines saved an estimated $540 billion in direct costs. A CDC analysis estimated that routine childhood vaccination of about 117 million children born in 1994–2023 will avert 1,129,000 deaths and save US$540 billion in direct costs and US$2.7 trillion in societal costs over their lifetimes. (CDC, MMWR)
  • 9 May 2023 $5 billion for next-generation COVID-19 vaccines and treatments. As the COVID-19 public health emergency ended, HHS described an investment of US$5 billion in Project NextGen to develop next-generation COVID-19 vaccines and treatments. (HHS (fact sheet))

Recent cases

  • September 2026: reports noted that outbreaks in South Carolina and Pennsylvania were driving much of the late-summer increase, taking 2026 past double the 2025 total (Global Biodefense).

Our read: what the numbers add up to

This is one of the few pages in the section where the direction is plainly upward, and on two fronts at once. Measles has already reached 3,887 confirmed cases by 1 October 2026, against 2,289 for the whole of 2025, and influenza and pneumonia have moved from 11th to 8th place among causes of death. Neither shift looks like a reporting artefact; both show up in independent measures.

Read together, the two stories share a thread that the bullets do not spell out: both are diseases where vaccination does most of the protective work, and both are hitting hardest where protection is thin. Measles needs about 95% coverage, and with 95% of cases linked to outbreaks, the spread is clearly clustered in communities with low uptake rather than diffuse across the country. On the flu side, the season was rated moderate overall but severe in children, and about 85% of the children who died, where status was known, had not been fully vaccinated. The rise in influenza and pneumonia deaths from 48,139 to 56,511 is probably partly strain-driven, since an H3N2-dominant season tends to be rough, but the child deaths point to the same gap.

The caveats are real. The CDC itself calls the 2025–2026 measles counts preliminary, the flu figures are estimates, and one bad flu season does not make a trend. What would change my reading is the next season: if flu deaths fall back with a milder strain, 2025 was mostly bad luck. If measles outbreaks keep igniting through the winter, the elimination status is the thing at risk. For now, the bottom line is that this is a genuine deterioration, concentrated where vaccination has slipped.

Press releases and official reports, 2023–2026

Five key releases a year for the last four years, newest first. Most are from federal agencies; a few news reports are included where they are the clearest public record of an event. Releases from 2007–2022 are in the expandable list after 2023.

2026

2025

2024

2023

View 20 years of major infectious disease press releases (2007–2026)80 more from 2007–2022, five a year, newest first

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Photo list

CDC bar chart of confirmed measles cases by month, 2020 to 2024
CDC chart of US measles cases by month of rash onset, January 2020 to March 2024, from MMWR. Photo: CDC, MMWR (Mathis et al.) via Wikimedia Commons, public domain.
A Navy hospital corpsman giving a seasonal flu vaccination
File photo: a seasonal flu vaccination clinic. Photo: Carmen Gibson, U.S. Navy via Wikimedia Commons, public domain.

How this page is built. Figures come from the official statistical releases linked above; where agencies publish preliminary numbers we say so, because they are revised. Photos are public-domain or Creative Commons images credited in each caption; file photos are illustrative and are not from the events described unless the caption says so. This page tracks trends and is not personal safety, medical, legal or financial advice.